Ryan & Maniskas, LLP Announces Investigation of Cellu Tissue Holdings Inc.
18 September 2010 - 7:15AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/clu) is
investigating potential claims against the board of directors of
Cellu Tissue Holdings Inc. ("Cellu Tissue" or the "Company")
(NYSE:CLU) concerning possible breaches of fiduciary duty and other
violations of law related to the Company’s efforts to sell Cellu
Tissue to Clearwater Paper Corporation in a transaction with a
value of approximately $502 million, including assumed debt.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to approval of the transaction
by Company’s board of directors; in particular, whether the Company
undertook a fair process to obtain fair consideration for all
shareholders of Cellu Tissue. For more information regarding our
investigation, please contact Ryan & Maniskas, LLP (Richard A.
Maniskas, Esquire) toll-free at (877) 316-3218 or by email at
rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/clu.
Under the terms of the agreement, Cellu Tissue shareholders will
receive $12.00 in cash for each share of Cellu Tissue common stock
they hold.
If you own shares of Cellu Tissue and would like to learn more
about these claims or if you wish to discuss these matters and have
any questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/clu. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan and Maniskas, LLP is devoted to protecting the interests
of individual and institutional investors in shareholder actions in
state and federal courts nationwide.
Canada Life (NYSE:CLU)
Historical Stock Chart
From Oct 2024 to Nov 2024
Canada Life (NYSE:CLU)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Cellu Tissue Holdings USD0.01 (New York Stock Exchange): 0 recent articles
More Ryan & Maniskas, LLP News Articles